This article, published in The Lancet Journal on 10th, October 2014 deals with the ethics and practice of randomized controlled trials in the case of Ebola hemorrhagic fever epidemic.
In the randomized trials patients are divided into different groups receiving various treatments, the distribution between the groups being formed by drawing of lots (also called randomization) compared to a reference product. The reference used may be a placebo or a recognized effective drug.
